Black Rock Inc. Bristol Myers Squibb CO Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Black Rock Inc. holds 158,658,853 shares of BMY stock, worth $7.45 Billion. This represents 0.15% of its overall portfolio holdings.
Number of Shares
158,658,853
Previous 162,561,081
2.4%
Holding current value
$7.45 Billion
Previous $8.82 Billion
25.26%
% of portfolio
0.15%
Previous 0.21%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,809Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.99 Billion0.22% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.08 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.45 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.12 Billion0.83% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.6MShares$2.85 Billion0.71% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.9B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...